MRPS9-AS1

Across TCGA pan-cancer cohorts, MRPS9-AS1 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated MRPS9-AS1 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MRPS9-AS1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MRPS9-AS1 expression acts as an unfavorable survival marker, although some lineages such as BLCA and PAAD show a favorable association.

BLCA, STAD, and ACC are the cancer types where MRPS9-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Quartile	All	0.499	0.266	.001	95	view →
STAD	DFS	Median	III,IV	0.341	0.622	<.001	78	view →
ACC	DFS	Tertile	III,IV	0.111	0.645	.006	65	view →
KIRP	OS	Median	III,IV	0.182	0.641	.001	40	view →
KIRC	OS	Median	All	0.466	0.710	<.001	38	view →
PAAD	OS	Median	II,III,IV	0.603	0.310	.002	27	view →
UVM	DFS	Tertile	III,IV	0.388	0.758	.021	17	view →
BRCA	OS	Quartile	III,IV	0.889	0.727	.004	16	view →
GBM	OS	Quartile	All	0.646	0.313	.012	15	view →
PRAD	DFS	Quartile	All	0.910	0.966	.003	12	view →
LGG	DFS	Quartile	All	0.770	0.859	.010	10	view →
MESO	OS	Median	All	0.318	0.447	.021	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

MRPS9-AS1–BLCA (DFS)

Open the BLCA breakdown →